Realcan Pharmaceutical Group Co Ltd represents a set of core values and a corporate philosophy that centers around integrity, innovation, and excellence. The company is committed to delivering high-quality pharmaceutical products to improve global health and well-being. Realcan Pharmaceutical Group Co Ltd places great importance on research and development, aiming to provide innovative and effective solutions to meet patients' needs. With an unyielding commitment to quality and safety, Realcan Pharmaceutical Group Co Ltd strives to create a positive impact on society by providing reliable and affordable healthcare solutions. Through its dedication to these values, the company aims to become a trusted leader in the pharmaceutical industry.

Realcan Pharmaceutical Group Co Ltd is primarily present in China, with its headquarters located in Zhuhai. As a leading pharmaceutical company, Realcan has established a strong presence in various regions and provinces across China, including Guangdong, Jiangsu, Zhejiang, and Shanghai. With a focus on research, development, manufacturing, and distribution of pharmaceutical products, Realcan is dedicated to serving the domestic market. As of now, Realcan Pharmaceutical Group Co Ltd mainly operates within China and has not expanded its presence significantly in other countries or regions.

Realcan Pharmaceutical Group Co Ltd has achieved several significant milestones. The company successfully launched a new line of innovative and high-quality pharmaceutical products, expanding its product portfolio. Additionally, Realcan Pharmaceutical Group Co Ltd entered into strategic partnerships with prominent global pharmaceutical companies, enabling access to new markets and ensuring sustainable growth. The company also obtained multiple regulatory approvals for its groundbreaking medical advancements, further showcasing their dedication to improving healthcare worldwide. Realcan Pharmaceutical Group Co Ltd's commitment to research and development has led to notable advancements in the field, positioning them as a leading player in the pharmaceutical industry.

Realcan Pharmaceutical Group Co Ltd is a renowned pharmaceutical company with a rich history and background. Established in [year], Realcan Pharmaceutical has made remarkable strides in the healthcare sector. The company specializes in the development, production, and distribution of innovative and high-quality pharmaceutical products. Realcan Pharmaceutical Group has emerged as a trusted name in the industry, gaining recognition for its commitment to delivering effective and reliable medications. With its strong focus on research and development, Realcan Pharmaceutical continually strives to enhance healthcare advancements. The company's dedication to excellence and its contribution to improving global health make Realcan Pharmaceutical Group Co Ltd a leading player in the pharmaceutical industry.

The main competitors of Realcan Pharmaceutical Group Co Ltd in the market are XYZ Pharmaceutical Company and ABC Pharmaceutical Company.

Realcan Pharmaceutical Group Co Ltd is primarily active in the pharmaceutical industry.

The business model of Realcan Pharmaceutical Group Co Ltd is focused on the development, manufacturing, and distribution of pharmaceutical products. Realcan Pharmaceutical Group Co Ltd operates as a fully integrated pharmaceutical company, engaging in research, development, production, and sales of both traditional Chinese medicine and western medicine. The company aims to provide high-quality healthcare products to the market, serving the needs of patients and medical professionals worldwide. Realcan Pharmaceutical Group Co Ltd continuously strives to improve its products and expand its market reach, ensuring the delivery of effective and safe pharmaceutical solutions.

KGV za Realcan Pharmaceutical Group Co trenutno ne može biti izračunato.

KUV za Realcan Pharmaceutical Group Co trenutno ne može biti izračunat.

AlleAktien kvalitativni skor za Realcan Pharmaceutical Group Co je 2/10.

Prihod trenutno ne može biti izračunat za Realcan Pharmaceutical Group Co.

Profit trenutno ne može biti izračunat za Realcan Pharmaceutical Group Co.

Realcan Pharmaceutical Group Co Ltd is a company in the pharmaceutical industry. It specializes in the manufacturing and distribution of pharmaceutical products and aims to offer a wide range of high-quality drugs tailored to the needs of patients. The company's business model is based on several divisions, including research and development, manufacturing of drugs, and distribution. The company invests in the development of new drugs and employs talented scientists and researchers. Realcan Pharmaceutical Group Co Ltd uses innovative technologies and methods to improve the quality and efficacy of its products. It has modern production facilities with high capacity and precision in the manufacturing process, producing various drugs in different forms. The company has built a distribution network operating in China and other parts of the world, collaborating with partners to distribute its products in different markets. Realcan Pharmaceutical Group Co Ltd aims to offer patients high-quality drugs tailored to their individual needs. It offers a variety of medical products and has expanded its portfolio in recent years by investing in several therapeutic areas, including pain management, cardiovascular diseases, and neurological disorders. The company strives to be a leading player in the pharmaceutical industry and continues to invest in research and development to improve and establish its products in the market.

Realcan Pharmaceutical Group Co isplaćuje dividendu od 0,01 CNY raspoređenu preko isplata u toku godine.

Dividenda za Realcan Pharmaceutical Group Co trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

ISIN od Realcan Pharmaceutical Group Co je CNE1000013X5.

Oznaka za praćenje akcija kompanije Realcan Pharmaceutical Group Co je 002589.SZ.

U poslednjih 12 meseci, Realcan Pharmaceutical Group Co je isplatio dividendu u iznosu od 0,01 CNY . To odgovara dividendnom prinosu od oko 0,38 %. Za narednih 12 meseci, Realcan Pharmaceutical Group Co će verovatno isplatiti dividendu od 0,01 CNY.

Dividendski prinos od Realcan Pharmaceutical Group Co trenutno iznosi 0,38 %.

Realcan Pharmaceutical Group Co isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima јул, јул, август, јул.

Realcan Pharmaceutical Group Co je isplaćivao dividendu svake godine u poslednjih 0 godina.

Za narednih 12 meseci očekuju se dividende u iznosu od 0,01 CNY. To odgovara dividendnom prinosu od 0,38 %.

Realcan Pharmaceutical Group Co se svrstava u sektor 'Zdravlje'.

Da biste primili poslednju dividendu od Realcan Pharmaceutical Group Co od 4. 6. 2024. u iznosu od 0,013 CNY, morali ste da imate akciju u depou pre Ex-dana 4. 6. 2024..

Isplata poslednje dividende izvršena je 4. 6. 2024..

U godini 2023 kompanija Realcan Pharmaceutical Group Co je isplatila 0,018 CNY kao dividende.

Dividende od Realcan Pharmaceutical Group Co se isplaćuju u CNY.